MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update ...

Data from an open-label trial showed that foralumab treatment eased fatigue and lessened disability for some people with ...

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody® sonelokimab across ...

The open-label safety population included all patients who completed ... the decrease in MRI scores differed significantly between ETN and PBO.14 SPARCC SIJ and spinal MRI scores continued improving ...

He did not have any pain or neurological deficits from his thoracic spine lesion. Given his PD-L1 ... Initial brain imaging with CT and MRI and routine serum testing were unremarkable. Lumbar puncture ...

Certain spinal cord lesions in people with MS show damage to nerve fibers despite having preserved myelin content, a possible ...

To explore the role of brain and spinal cord MRI features in differentiating patients with suspected central nervous system (CNS) inflammatory diseases.Prospective data from 125 patients undergoing ...

Plano-based Texas Back Institute is joining Aclarion’s Clarity trial for augmented intelligence spine diagnostics. The Clarity trial is examining the Nociscan diagnostic tool’s clinical and economic ...

Texas Back Institute is a world leader in advancing spine technology, science, and education, as well as patient care ...

Clinical trials of a new, minimally invasive treatment for degenerated spinal discs have produced impressive results, significantly reducing back pain severity and improving function. It could mean ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer, prostate ...